Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
$6.75
+3.5%
$5.30
$2.25
$7.09
$625.54M2.211.77 million shs903,379 shs
Cybin Inc. stock logo
CYBN
Cybin
$6.26
+3.8%
$6.45
$4.81
$13.88
$157.68M0.63395,580 shs1.04 million shs
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$7.21
-1.6%
$9.11
$3.39
$14.69
$584.59M2.131.28 million shs915,858 shs
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
$8.48
+2.2%
$8.69
$4.95
$9.62
$594.33M0.96416,913 shs349,555 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
+3.53%+7.31%+37.76%+52.71%+5.63%
Cybin Inc. stock logo
CYBN
Cybin
+3.81%+7.01%+4.33%-19.02%-45.14%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
-1.64%-3.35%-26.88%-23.70%+106.00%
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
+2.17%+2.66%-3.42%+23.80%+22.54%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
$6.75
+3.5%
$5.30
$2.25
$7.09
$625.54M2.211.77 million shs903,379 shs
Cybin Inc. stock logo
CYBN
Cybin
$6.26
+3.8%
$6.45
$4.81
$13.88
$157.68M0.63395,580 shs1.04 million shs
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$7.21
-1.6%
$9.11
$3.39
$14.69
$584.59M2.131.28 million shs915,858 shs
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
$8.48
+2.2%
$8.69
$4.95
$9.62
$594.33M0.96416,913 shs349,555 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
+3.53%+7.31%+37.76%+52.71%+5.63%
Cybin Inc. stock logo
CYBN
Cybin
+3.81%+7.01%+4.33%-19.02%-45.14%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
-1.64%-3.35%-26.88%-23.70%+106.00%
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
+2.17%+2.66%-3.42%+23.80%+22.54%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
2.67
Moderate Buy$16.00137.04% Upside
Cybin Inc. stock logo
CYBN
Cybin
0.00
N/AN/AN/A
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
2.83
Moderate Buy$13.4286.13% Upside
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest CYBN, CMPS, NAGE, and SIGA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/13/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$7.00 ➝ $14.00
10/8/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/8/2025
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/27/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/27/2025
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
8/11/2025
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$11.00 ➝ $12.00
8/4/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$45.00 ➝ $40.00
8/1/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$15.00
(Data available from 10/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
N/AN/AN/AN/A$2.26 per shareN/A
Cybin Inc. stock logo
CYBN
Cybin
N/AN/AN/AN/A$0.19 per shareN/A
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$99.60M5.77$0.06 per share123.92$0.60 per share12.02
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
$138.72M4.38$0.85 per share9.92$3.02 per share2.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
-$155.12M-$1.84N/AN/AN/AN/A-87.89%-57.77%10/30/2025 (Estimated)
Cybin Inc. stock logo
CYBN
Cybin
-$35.93M-$4.60N/AN/AN/AN/A-93.17%-84.68%N/A
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$8.55M$0.2134.33N/A15.24%23.12%15.53%N/A
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
$59.21M$1.137.506.78N/A45.73%40.52%35.62%11/6/2025 (Estimated)

Latest CYBN, CMPS, NAGE, and SIGA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/30/2025Q3 2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
-$0.40N/AN/AN/AN/AN/A
8/6/2025Q2 2025
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$0.02$0.04+$0.02$0.04$28.55 million$31.12 million
8/5/2025Q2 2025
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
N/A$0.49N/A$0.49N/A$81.12 million
7/31/2025Q2 2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
-$0.37-$0.38-$0.01-$0.41N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
N/AN/AN/AN/AN/A
Cybin Inc. stock logo
CYBN
Cybin
N/AN/AN/AN/AN/A
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
N/AN/AN/AN/AN/A
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
0.16
8.82
8.82
Cybin Inc. stock logo
CYBN
Cybin
N/A
2.61
2.61
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
N/A
3.88
3.24
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
N/A
10.09
8.52

Institutional Ownership

CompanyInstitutional Ownership
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
46.19%
Cybin Inc. stock logo
CYBN
Cybin
17.94%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
15.41%
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
55.40%

Insider Ownership

CompanyInsider Ownership
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
3.93%
Cybin Inc. stock logo
CYBN
Cybin
15.00%
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
9.39%
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
1.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
12095.94 million92.17 millionOptionable
Cybin Inc. stock logo
CYBN
Cybin
5025.19 million170.21 millionNot Optionable
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
12079.75 million72.26 millionN/A
Siga Technologies Inc. stock logo
SIGA
Siga Technologies
4071.61 million70.21 millionOptionable

Recent News About These Companies

Discovering US Market Gems October 2025
SIGA (SIGA) Q2 Revenue Soars 272%
SIGA Technologies Inc Dividends - Morningstar

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
COMPASS Pathways stock logo

COMPASS Pathways NASDAQ:CMPS

$6.75 +0.23 (+3.53%)
Closing price 10/20/2025 04:00 PM Eastern
Extended Trading
$6.78 +0.03 (+0.43%)
As of 06:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Cybin stock logo

Cybin OTCMKTS:CYBN

$6.26 +0.23 (+3.81%)
As of 10/20/2025 04:10 PM Eastern

Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in Phase 1/2a clinical trial to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine, which is in Phase 1 clinical trial for treating generalized anxiety disorders; and CYB005, a phenethylamine derivative, which in preclinical stage to treat neuroinflammation. It has also developed EMBARK, a psychological support model that integrates clinical approaches to promote supportive healing with psychedelic medicine. The company is headquartered in Toronto, Canada.

Niagen Bioscience stock logo

Niagen Bioscience NASDAQ:NAGE

$7.21 -0.12 (-1.64%)
As of 10/20/2025 04:00 PM Eastern

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Siga Technologies stock logo

Siga Technologies NASDAQ:SIGA

$8.48 +0.18 (+2.17%)
Closing price 10/20/2025 04:00 PM Eastern
Extended Trading
$8.48 -0.01 (-0.06%)
As of 06:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.